News
Strong Q1 sales of $137.3M showcase Madrigal Pharmaceuticals, Inc.'s Rezdiffra's growth in non-cirrhotic NASH. Click for my ...
Lisandro Madrigal, the owner of Sacramento’s taqueria chain Chando’s Tacos, is scheduled to appear in court at 8:45 a.m. on ...
Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for ...
Madrigal Pharmaceuticals ( NASDAQ: MDGL) said it has signed a global licensing deal with CSPC Pharmaceutical for SYH2086, a ...
CEO touts 'amazing' sales success of new drug, but firm's stock slumps Montco firm's shares soar on huge sales increase of ...
U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for a ...
3d
US Weekly on MSNScheana Shay, Peter Madrigal Argue Over Loyalty to Lisa Vanderpump: ‘Crazy How Quick Things Changed’Scheana Shay's candid comments about her falling out with Lisa Vanderpump upset one of her former Vanderpump Rules costars.
An experimental Latin music series, Bajo La Luna will bring Y La Bamba, Silvia Pérez Cruz and La Muchacha to the Ford Theatre ...
Conshohocken, Pa. Friday, August 1, 2025, 15:00 Hrs [IST] ...
USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...
Madrigal Pharmaceuticals secures global rights to SYH2086, aiming to enhance MASH treatment with innovative combination ...
License agreement supports Madrigal’s pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra™ (resmetirom) Combining Rezdiffra with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results